Search research articles
Contact Us
Filters
Showing results (241-250 of 256) with videos related to
Page
of 26
Sort By:
BMC Cancer
|
January 18, 2023
DUPAN-II normalisation as a biological indicator during preoperative chemoradiation therapy for resectable and borderline resectable pancreatic cancer
Shinichiro Hasegawa, Hidenori Takahashi, Hirofumi Akita, et al.
Plos One
|
January 4, 2014
Cell cycle-dependent Rho GTPase activity dynamically regulates cancer cell motility and invasion in vivo
Yoshinori Kagawa, Shinji Matsumoto, Yuji Kamioka, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
April 17, 2024
The emerging emetogenicity of trifluridine/tipiracil (TAS‑102) from patient self-reporting: a multicenter, prospective, observational study
Hironori Fujii, Masami Tsuchiya, Daichi Watanabe, et al.
International Journal of Clinical Oncology
|
May 16, 2024
2023 Japan Society of clinical oncology clinical practice guidelines update for antiemesis
Hirotoshi Iihara, Masakazu Abe, Makoto Wada, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
March 9, 2020
Decreased CT-number in the pancreatic parenchyma is a reliable imaging biomarker of the presence of malignancies in patients with high-risk intraductal papillary mucinous neoplasm
Tomoki Abe, Daisaku Yamada, Kei Asukai, et al.
International Journal of Oncology
|
January 29, 2013
Depletion of JARID1B induces cellular senescence in human colorectal cancer
Katsuya Ohta, Naotsugu Haraguchi, Yoshihiro Kano, et al.
Science Translational Medicine
|
February 23, 2018
Eosinophil depletion suppresses radiation-induced small intestinal fibrosis
Naoki Takemura, Yosuke Kurashima, Yuki Mori, et al.
Gastrointestinal Endoscopy
|
April 10, 2025
Safety and feasibility of intensive endoscopic interventions for delayed perforation after colorectal endoscopic submucosal dissection (with video)
Satoki Shichijo, Yoji Takeuchi, Daiki Kitagawa, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
June 11, 2026
Immunotherapy-Facilitated Conversion Surgery for Biliary Tract Cancer: A Case Series of Long-Term Survivors Following Durvalumab Combined With Gemcitabine and Cisplatin
Shinichiro Hasegawa, Hiroshi Wada, Ryoji Takada, et al.
International Journal of Clinical Oncology
|
November 21, 2024
Clinical benefits of adding olanzapine to 5-HT<sub>3</sub> receptor antagonist, NK<sub>1</sub> receptor antagonist, and dexamethasone for the prevention of nausea and vomiting in highly emetogenic chemotherapy: a systematic review and meta-analysis of the Clinical Practice Guidelines for Antiemesis 2023 from the Japan Society of Clinical Oncology
Michiyasu Murakami, Yoshiharu Miyata, Kazuhisa Nakashima, et al.
Page
of 26
Search research articles
Search
Showing results (241-250 of 256) with videos related to
Sort By:
Page
of 26
BMC Cancer
|
January 18, 2023
DUPAN-II normalisation as a biological indicator during preoperative chemoradiation therapy for resectable and borderline resectable pancreatic cancer
Shinichiro Hasegawa, Hidenori Takahashi, Hirofumi Akita, et al.
Plos One
|
January 4, 2014
Cell cycle-dependent Rho GTPase activity dynamically regulates cancer cell motility and invasion in vivo
Yoshinori Kagawa, Shinji Matsumoto, Yuji Kamioka, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
April 17, 2024
The emerging emetogenicity of trifluridine/tipiracil (TAS‑102) from patient self-reporting: a multicenter, prospective, observational study
Hironori Fujii, Masami Tsuchiya, Daichi Watanabe, et al.
International Journal of Clinical Oncology
|
May 16, 2024
2023 Japan Society of clinical oncology clinical practice guidelines update for antiemesis
Hirotoshi Iihara, Masakazu Abe, Makoto Wada, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
March 9, 2020
Decreased CT-number in the pancreatic parenchyma is a reliable imaging biomarker of the presence of malignancies in patients with high-risk intraductal papillary mucinous neoplasm
Tomoki Abe, Daisaku Yamada, Kei Asukai, et al.
International Journal of Oncology
|
January 29, 2013
Depletion of JARID1B induces cellular senescence in human colorectal cancer
Katsuya Ohta, Naotsugu Haraguchi, Yoshihiro Kano, et al.
Science Translational Medicine
|
February 23, 2018
Eosinophil depletion suppresses radiation-induced small intestinal fibrosis
Naoki Takemura, Yosuke Kurashima, Yuki Mori, et al.
Gastrointestinal Endoscopy
|
April 10, 2025
Safety and feasibility of intensive endoscopic interventions for delayed perforation after colorectal endoscopic submucosal dissection (with video)
Satoki Shichijo, Yoji Takeuchi, Daiki Kitagawa, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
June 11, 2026
Immunotherapy-Facilitated Conversion Surgery for Biliary Tract Cancer: A Case Series of Long-Term Survivors Following Durvalumab Combined With Gemcitabine and Cisplatin
Shinichiro Hasegawa, Hiroshi Wada, Ryoji Takada, et al.
International Journal of Clinical Oncology
|
November 21, 2024
Clinical benefits of adding olanzapine to 5-HT<sub>3</sub> receptor antagonist, NK<sub>1</sub> receptor antagonist, and dexamethasone for the prevention of nausea and vomiting in highly emetogenic chemotherapy: a systematic review and meta-analysis of the Clinical Practice Guidelines for Antiemesis 2023 from the Japan Society of Clinical Oncology
Michiyasu Murakami, Yoshiharu Miyata, Kazuhisa Nakashima, et al.
Page
of 26